摘要
目的探讨利巴韦林雾化吸入辅助治疗小儿肺炎的临床疗效。方法将224例肺炎患儿随机分成利巴韦林雾化治疗组112例（治疗组）和常规治疗组112例（对照组），两组均给予常规抗感染及对症支持治疗，治疗组给予10—15mg／d利巴韦林雾化吸入，每天2次，疗程7d。结果治疗组和对照组总有效率分别为91．07％和82．14％，差异有统计学意义（χ^2=5．64，P〈0．05），两组均未见明显不良反应。结论利巴韦林雾化吸入辅助治疗小儿肺炎安全、有效，值得临床应用。
Objective To investigate the curative effect of ribavirin atomization inhalation on the young children＇s pneuatonia. Methods 224 young children with pneumonia were randomly divided into treatment groups and control group,besides treated with the ordinary therapeutical methods,the treatment group were given ribavirin atomization inhalation 10mg/（ kg@ d） ,bid, continued for 7 days, and the control group were given ordinary therapeutical method. Results The treatment group＇ S curative rate was 91.07%, and the control group＇s effective rate was 82. 14% ,compared with the control group, there was significantly statistical difference （ χ2 = 5.64, P 〈 0.05 ）. Conclusion Ribavirin atomization inhalation treatment on young child with pneumonia had a higher curative rate and low incidence of adverse reactions,and it was worthy of being widely applied in clinical practice.
出处
《中国基层医药》
CAS
2012年第2期175-176,共2页
Chinese Journal of Primary Medicine and Pharmacy
关键词
肺炎
利巴韦林
雾化吸入
儿童
Pneumomia
Ribavirin
Atomization inhalation
Child
